ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
A new PPAR agonist (GQ-11) modulates impaired inflammation and induces re-epithelization in diabetic wound healing (2018)
Silva, Jacqueline Cavalcante; Pitta, Ivan da Rocha; Pitta, Marina Galdino; Koh, Timothy Jon; Abdalla, Dulcinéia Saes Parra
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Congress of the Brazilian Association of Pharmaceutical Sciences/ABCF. Unidade: FCF
Subjects: DIABETES MELLITUS, AMPUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jacqueline Cavalcante et al. A new PPAR agonist (GQ-11) modulates impaired inflammation and induces re-epithelization in diabetic wound healing. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf. Acesso em: 14 out. 2024. , 2018
APA
Silva, J. C., Pitta, I. da R., Pitta, M. G., Koh, T. J., & Abdalla, D. S. P. (2018). A new PPAR agonist (GQ-11) modulates impaired inflammation and induces re-epithelization in diabetic wound healing. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
NLM
Silva JC, Pitta I da R, Pitta MG, Koh TJ, Abdalla DSP. A new PPAR agonist (GQ-11) modulates impaired inflammation and induces re-epithelization in diabetic wound healing [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 47 res. 63.[citado 2024 out. 14 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Vancouver
Silva JC, Pitta I da R, Pitta MG, Koh TJ, Abdalla DSP. A new PPAR agonist (GQ-11) modulates impaired inflammation and induces re-epithelization in diabetic wound healing [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 47 res. 63.[citado 2024 out. 14 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Artigo de periodico
New thiazolidinediones affect endothelial cell activation and angiogenesis (2016)
Rudnicki, Martina; Tripodi, Gustavo Luis; Ferrer, Renila; Boscá, Lisardo; Pitta, Marina G. R; Pitta, Ivan Rocha; Abdalla, Dulcinéia Saes Parra
Source: European Journal of Pharmacology. Unidade: FCF
Subjects: CÉLULAS ENDOTELIAIS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUDNICKI, Martina et al. New thiazolidinediones affect endothelial cell activation and angiogenesis. European Journal of Pharmacology, v. 782, p. 98-106, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2016.04.038. Acesso em: 14 out. 2024.
APA
Rudnicki, M., Tripodi, G. L., Ferrer, R., Boscá, L., Pitta, M. G. R., Pitta, I. R., & Abdalla, D. S. P. (2016). New thiazolidinediones affect endothelial cell activation and angiogenesis. European Journal of Pharmacology, 782, 98-106. doi:10.1016/j.ejphar.2016.04.038
NLM
Rudnicki M, Tripodi GL, Ferrer R, Boscá L, Pitta MGR, Pitta IR, Abdalla DSP. New thiazolidinediones affect endothelial cell activation and angiogenesis [Internet]. European Journal of Pharmacology. 2016 ; 782 98-106.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.ejphar.2016.04.038
Vancouver
Rudnicki M, Tripodi GL, Ferrer R, Boscá L, Pitta MGR, Pitta IR, Abdalla DSP. New thiazolidinediones affect endothelial cell activation and angiogenesis [Internet]. European Journal of Pharmacology. 2016 ; 782 98-106.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.ejphar.2016.04.038
Artigo de periodico
New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice (2016)
Silva, Jacqueline Cavalcante; César, Fernanda Andrade de; Oliveira, Edson Mendes de; Turato, Walter Miguel; Tripodi, Gustavo L; Castilho, Gabriela; Lima, Adriana Machado; Las Heras, Beatriz de; Boscá, Lisardo; Rabello, Marcelo M; Hernandes, Marcelo Zaldini; Pitta, Marina G. R; Pitta, Ivan Rocha; Passarelli, Marisa; Rudnicki, Martina; Abdalla, Dulcinéia Saes Parra
Source: Pharmacological Research. Unidades: FCF, FM
Subjects: ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES, EXPRESSÃO GÊNICA, ADIPONECTINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jacqueline Cavalcante et al. New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice. Pharmacological Research, v. 104, p. 49-60, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2015.12.010. Acesso em: 14 out. 2024.
APA
Silva, J. C., César, F. A. de, Oliveira, E. M. de, Turato, W. M., Tripodi, G. L., Castilho, G., et al. (2016). New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice. Pharmacological Research, 104, 49-60. doi:10.1016/j.phrs.2015.12.010
NLM
Silva JC, César FA de, Oliveira EM de, Turato WM, Tripodi GL, Castilho G, Lima AM, Las Heras B de, Boscá L, Rabello MM, Hernandes MZ, Pitta MGR, Pitta IR, Passarelli M, Rudnicki M, Abdalla DSP. New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice [Internet]. Pharmacological Research. 2016 ; 104 49-60.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.phrs.2015.12.010
Vancouver
Silva JC, César FA de, Oliveira EM de, Turato WM, Tripodi GL, Castilho G, Lima AM, Las Heras B de, Boscá L, Rabello MM, Hernandes MZ, Pitta MGR, Pitta IR, Passarelli M, Rudnicki M, Abdalla DSP. New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice [Internet]. Pharmacological Research. 2016 ; 104 49-60.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.phrs.2015.12.010
Artigo de periodico
Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation (2015)
Garcia, Giani Martins; Oliveira,Líliam Teixeira; Pitta, Ivan da Rocha; Lima, Maria do Carmo Alves de; Vilela, José Mário Carneiro; Andrade, Margareth Spangler; Abdalla, Dulcinéia Saes Parra ; Mosqueira, Vanessa Carla Furtado
Source: Journal of Controlled Release. Unidade: FCF
Subjects: FARMACOCINÉTICA, NANOTECNOLOGIA, CÁPSULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Giani Martins et al. Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation. Journal of Controlled Release, v. 209, p. 207-218, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2015.04.033. Acesso em: 14 out. 2024.
APA
Garcia, G. M., Oliveira, L. T., Pitta, I. da R., Lima, M. do C. A. de, Vilela, J. M. C., Andrade, M. S., et al. (2015). Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation. Journal of Controlled Release, 209, 207-218. doi:10.1016/j.jconrel.2015.04.033
NLM
Garcia GM, Oliveira LT, Pitta I da R, Lima M do CA de, Vilela JMC, Andrade MS, Abdalla DSP, Mosqueira VCF. Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation [Internet]. Journal of Controlled Release. 2015 ; 209 207-218.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.jconrel.2015.04.033
Vancouver
Garcia GM, Oliveira LT, Pitta I da R, Lima M do CA de, Vilela JMC, Andrade MS, Abdalla DSP, Mosqueira VCF. Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation [Internet]. Journal of Controlled Release. 2015 ; 209 207-218.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.jconrel.2015.04.033
Artigo de periodico
New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice (2015)
César, Fernanda A; Rudnicki, Martina; Heras, Beatriz de Las; Boscá, Lisardo; Lima, Maria C. A; Pitta, Ivan R; Abdalla, Dulcinéia Saes Parra
Source: Vascular Pharmacology. Unidade: FCF
Subjects: ARTERIOSCLEROSE, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÉSAR, Fernanda A et al. New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice. Vascular Pharmacology, v. 71, p. 174-180, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.vph.2015.03.009. Acesso em: 14 out. 2024.
APA
César, F. A., Rudnicki, M., Heras, B. de L., Boscá, L., Lima, M. C. A., Pitta, I. R., & Abdalla, D. S. P. (2015). New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice. Vascular Pharmacology, 71, 174-180. doi:10.1016/j.vph.2015.03.009
NLM
César FA, Rudnicki M, Heras B de L, Boscá L, Lima MCA, Pitta IR, Abdalla DSP. New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice [Internet]. Vascular Pharmacology. 2015 ; 71 174-180.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.vph.2015.03.009
Vancouver
César FA, Rudnicki M, Heras B de L, Boscá L, Lima MCA, Pitta IR, Abdalla DSP. New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice [Internet]. Vascular Pharmacology. 2015 ; 71 174-180.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.vph.2015.03.009
Trabalho de evento-resumo
Novel arylidene-thiazolidinediones with no adipogenic effects (2013)
Silva, Jacqueline Cavalcante; Saito, Cristiane Akemi Iamamoto; César, Fernanda Andrade de; Rudnicki, Martina; Galdino, Sergio Luiz; Pitta, Ivan da Rocha; Lima, M. C; Boss, M; Knap, T; Kemmerer, M; Brüne, Bernhard; Namgaladze, Dmitry; Abdalla, Dulcinéia Saes Parra
Source: Abstracts. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Subjects: INSULINA, HIPERGLICEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jacqueline Cavalcante et al. Novel arylidene-thiazolidinediones with no adipogenic effects. 2013, Anais.. Gothenburg: European Atherosclerosis Society, 2013. . Acesso em: 14 out. 2024.
APA
Silva, J. C., Saito, C. A. I., César, F. A. de, Rudnicki, M., Galdino, S. L., Pitta, I. da R., et al. (2013). Novel arylidene-thiazolidinediones with no adipogenic effects. In Abstracts. Gothenburg: European Atherosclerosis Society.
NLM
Silva JC, Saito CAI, César FA de, Rudnicki M, Galdino SL, Pitta I da R, Lima MC, Boss M, Knap T, Kemmerer M, Brüne B, Namgaladze D, Abdalla DSP. Novel arylidene-thiazolidinediones with no adipogenic effects. Abstracts. 2013 ;[citado 2024 out. 14 ]
Vancouver
Silva JC, Saito CAI, César FA de, Rudnicki M, Galdino SL, Pitta I da R, Lima MC, Boss M, Knap T, Kemmerer M, Brüne B, Namgaladze D, Abdalla DSP. Novel arylidene-thiazolidinediones with no adipogenic effects. Abstracts. 2013 ;[citado 2024 out. 14 ]
Trabalho de evento-resumo
New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes (2012)
Saito, Cristiane Akemi Iamamoto; Ferrer, Renila; Rudnicki, Martina; César, Fernanda Andrade de; Lima, Maria C. A; Galdino, Suely Lins; Pitta, Ivan da Rocha; Abdalla, Dulcinéia Saes Parra
Source: Abstracts. Conference titles: International Symposium on Atherosclerosis. Unidade: FCF
Assunto: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAITO, Cristiane Akemi Iamamoto et al. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. 2012, Anais.. Sydney: Australian Atherosclerosis Society, 2012. . Acesso em: 14 out. 2024.
APA
Saito, C. A. I., Ferrer, R., Rudnicki, M., César, F. A. de, Lima, M. C. A., Galdino, S. L., et al. (2012). New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. In Abstracts. Sydney: Australian Atherosclerosis Society.
NLM
Saito CAI, Ferrer R, Rudnicki M, César FA de, Lima MCA, Galdino SL, Pitta I da R, Abdalla DSP. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Abstracts. 2012 ;[citado 2024 out. 14 ]
Vancouver
Saito CAI, Ferrer R, Rudnicki M, César FA de, Lima MCA, Galdino SL, Pitta I da R, Abdalla DSP. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Abstracts. 2012 ;[citado 2024 out. 14 ]
Trabalho de evento-resumo
Novel thiazolidine-2,4-diones inhibit atherosclerotic lesion progression in LDL receptor-deficient mice (2012)
César, Fernanda Andrade de; Rudnicki, Martina; Saito, Cristiane Akemi Iamamoto; Galdino, Suely Lins; Pitta, Ivan Rocha; Lima, Maria C. A; Abdalla, Dulcinéia Saes Parra
Source: Abstracts. Conference titles: International Symposium on Atherosclerosis. Unidade: FCF
Subjects: ARTERIOSCLEROSE, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÉSAR, Fernanda Andrade de et al. Novel thiazolidine-2,4-diones inhibit atherosclerotic lesion progression in LDL receptor-deficient mice. 2012, Anais.. Sydney: Australian Atherosclerosis Society, 2012. . Acesso em: 14 out. 2024.
APA
César, F. A. de, Rudnicki, M., Saito, C. A. I., Galdino, S. L., Pitta, I. R., Lima, M. C. A., & Abdalla, D. S. P. (2012). Novel thiazolidine-2,4-diones inhibit atherosclerotic lesion progression in LDL receptor-deficient mice. In Abstracts. Sydney: Australian Atherosclerosis Society.
NLM
César FA de, Rudnicki M, Saito CAI, Galdino SL, Pitta IR, Lima MCA, Abdalla DSP. Novel thiazolidine-2,4-diones inhibit atherosclerotic lesion progression in LDL receptor-deficient mice. Abstracts. 2012 ;[citado 2024 out. 14 ]
Vancouver
César FA de, Rudnicki M, Saito CAI, Galdino SL, Pitta IR, Lima MCA, Abdalla DSP. Novel thiazolidine-2,4-diones inhibit atherosclerotic lesion progression in LDL receptor-deficient mice. Abstracts. 2012 ;[citado 2024 out. 14 ]
Trabalho de evento-resumo
Proangiogenic and anti-inflammatory properties of new thiazolidinediones in endothelial cells (2012)
Rudnicki, Martina; Saito, Cristiane Akemi Iamamoto; César, Fernanda Andrade de; Lima, Maria C. A; Galdino, Suely Lins; Pitta, Ivan da Rocha; Abdalla, Dulcinéia Saes Parra
Source: Abstracts. Conference titles: International Symposium on Atherosclerosis. Unidade: FCF
Assunto: CÉLULAS ENDOTELIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUDNICKI, Martina et al. Proangiogenic and anti-inflammatory properties of new thiazolidinediones in endothelial cells. 2012, Anais.. Sydney: Australian Atherosclerosis Society, 2012. . Acesso em: 14 out. 2024.
APA
Rudnicki, M., Saito, C. A. I., César, F. A. de, Lima, M. C. A., Galdino, S. L., Pitta, I. da R., & Abdalla, D. S. P. (2012). Proangiogenic and anti-inflammatory properties of new thiazolidinediones in endothelial cells. In Abstracts. Sydney: Australian Atherosclerosis Society.
NLM
Rudnicki M, Saito CAI, César FA de, Lima MCA, Galdino SL, Pitta I da R, Abdalla DSP. Proangiogenic and anti-inflammatory properties of new thiazolidinediones in endothelial cells. Abstracts. 2012 ;[citado 2024 out. 14 ]
Vancouver
Rudnicki M, Saito CAI, César FA de, Lima MCA, Galdino SL, Pitta I da R, Abdalla DSP. Proangiogenic and anti-inflammatory properties of new thiazolidinediones in endothelial cells. Abstracts. 2012 ;[citado 2024 out. 14 ]
Trabalho de evento-resumo periodico
New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes (2012)
Saito, Cristiane Akemi Iamamoto; Rudnicki, Martina; César, Fernanda Andrade de; Ferrer, Renila; Galdino, Suely Lins; Pitta, Ivan da Rocha; Lima, Maria C. A; Abdalla, Dulcinéia Saes Parra
Source: Vascular Pharmacology. Conference titles: European meeting on vascular biology and medicine (EMVBM). Unidade: FCF
Assunto: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAITO, Cristiane Akemi Iamamoto et al. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Vascular Pharmacology. new york: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 out. 2024. , 2012
APA
Saito, C. A. I., Rudnicki, M., César, F. A. de, Ferrer, R., Galdino, S. L., Pitta, I. da R., et al. (2012). New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Vascular Pharmacology. new york: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Saito CAI, Rudnicki M, César FA de, Ferrer R, Galdino SL, Pitta I da R, Lima MCA, Abdalla DSP. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Vascular Pharmacology. 2012 ; 56( 5-6): 376 res. P.13.17.[citado 2024 out. 14 ]
Vancouver
Saito CAI, Rudnicki M, César FA de, Ferrer R, Galdino SL, Pitta I da R, Lima MCA, Abdalla DSP. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Vascular Pharmacology. 2012 ; 56( 5-6): 376 res. P.13.17.[citado 2024 out. 14 ]
Trabalho de evento-resumo periodico
Anti-atherogenic and anti-inflammatory effects of novel thiazolidine-2,4-diones in RAW 264.7 macrophages and in low-density lipoprotein receptor-deficient mice (2012)
Cesar, A. Fernanda; Rudnicki, Martina; Saito, Cristiane Akemi Iamamoto; Galdino, Suely Lins; Pitta, Ivan da Rocha; Lima, Maria Carmo Alves; Abdalla, Dulcinéia Saes Parra
Source: Vascular Pharmacology. Conference titles: European meeting on vascular biology and medicine (EMVBM). Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS, LIPOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESAR, A. Fernanda et al. Anti-atherogenic and anti-inflammatory effects of novel thiazolidine-2,4-diones in RAW 264.7 macrophages and in low-density lipoprotein receptor-deficient mice. Vascular Pharmacology. new york: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 out. 2024. , 2012
APA
Cesar, A. F., Rudnicki, M., Saito, C. A. I., Galdino, S. L., Pitta, I. da R., Lima, M. C. A., & Abdalla, D. S. P. (2012). Anti-atherogenic and anti-inflammatory effects of novel thiazolidine-2,4-diones in RAW 264.7 macrophages and in low-density lipoprotein receptor-deficient mice. Vascular Pharmacology. new york: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cesar AF, Rudnicki M, Saito CAI, Galdino SL, Pitta I da R, Lima MCA, Abdalla DSP. Anti-atherogenic and anti-inflammatory effects of novel thiazolidine-2,4-diones in RAW 264.7 macrophages and in low-density lipoprotein receptor-deficient mice. Vascular Pharmacology. 2012 ; 56( 5-6): 371 res. P.13.2.[citado 2024 out. 14 ]
Vancouver
Cesar AF, Rudnicki M, Saito CAI, Galdino SL, Pitta I da R, Lima MCA, Abdalla DSP. Anti-atherogenic and anti-inflammatory effects of novel thiazolidine-2,4-diones in RAW 264.7 macrophages and in low-density lipoprotein receptor-deficient mice. Vascular Pharmacology. 2012 ; 56( 5-6): 371 res. P.13.2.[citado 2024 out. 14 ]
Trabalho de evento-resumo periodico
A novel thiazolidinedione with low activity on differentiation of mouse preosteoblasts and preadipocytes (2012)
Saito, C. A. I; Ferrer, R; César, Fernanda Andrade de; Lima, M. C. A; Galdino, Sergio Luiz; Pitta, Ivan da Rocha; Rudnicki, Martina; Abdalla, Dulcinéia Saes Parra
Source: Febs Journal. Conference titles: International Union of Biochemistry and Molecular Biology (IUBMB). Unidade: FCF
Subjects: ANTIDIABÉTICOS (HIPOGLICEMIANTES), OSTEOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAITO, C. A. I et al. A novel thiazolidinedione with low activity on differentiation of mouse preosteoblasts and preadipocytes. Febs Journal. Malden: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 out. 2024. , 2012
APA
Saito, C. A. I., Ferrer, R., César, F. A. de, Lima, M. C. A., Galdino, S. L., Pitta, I. da R., et al. (2012). A novel thiazolidinedione with low activity on differentiation of mouse preosteoblasts and preadipocytes. Febs Journal. Malden: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Saito CAI, Ferrer R, César FA de, Lima MCA, Galdino SL, Pitta I da R, Rudnicki M, Abdalla DSP. A novel thiazolidinedione with low activity on differentiation of mouse preosteoblasts and preadipocytes. Febs Journal. 2012 ; 279 562 res. P27-82.[citado 2024 out. 14 ]
Vancouver
Saito CAI, Ferrer R, César FA de, Lima MCA, Galdino SL, Pitta I da R, Rudnicki M, Abdalla DSP. A novel thiazolidinedione with low activity on differentiation of mouse preosteoblasts and preadipocytes. Febs Journal. 2012 ; 279 562 res. P27-82.[citado 2024 out. 14 ]
Trabalho de evento-resumo periodico
New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice (2011)
César, F. A; Rudnicki, Martina; Saito, C. A. I; Galdino, S. L; Lima, M. C. A; Pitta, Ivan da Rocha; Abdalla, Dulcinéia Saes Parra
Source: Atherosclerosis Supplements. Conference titles: Congress of the European-Atherosclerosis Society (EAS). Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÉSAR, F. A et al. New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 out. 2024. , 2011
APA
César, F. A., Rudnicki, M., Saito, C. A. I., Galdino, S. L., Lima, M. C. A., Pitta, I. da R., & Abdalla, D. S. P. (2011). New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
César FA, Rudnicki M, Saito CAI, Galdino SL, Lima MCA, Pitta I da R, Abdalla DSP. New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. 2011 ; 12( 1): 83 res. 387.[citado 2024 out. 14 ]
Vancouver
César FA, Rudnicki M, Saito CAI, Galdino SL, Lima MCA, Pitta I da R, Abdalla DSP. New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. 2011 ; 12( 1): 83 res. 387.[citado 2024 out. 14 ]
Trabalho de evento-resumo periodico
Anti-inflammatory and antioxidant effects of a new arylidene-thiazolidinedione (2010)
Faine, Luciane Aparecida; Rudnicki, Martina; César, Fernanda Andrade de; Galdino, Suely Lins; Pitta, Ivan da Rocha; Lima, Maria do Carmo Alves; Boscá, Lisardo; Heras, Beatriz de Las; Abdalla, Dulcinéia Saes Parra
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS, ANTIOXIDANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAINE, Luciane Aparecida et al. Anti-inflammatory and antioxidant effects of a new arylidene-thiazolidinedione. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 out. 2024. , 2010
APA
Faine, L. A., Rudnicki, M., César, F. A. de, Galdino, S. L., Pitta, I. da R., Lima, M. do C. A., et al. (2010). Anti-inflammatory and antioxidant effects of a new arylidene-thiazolidinedione. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Faine LA, Rudnicki M, César FA de, Galdino SL, Pitta I da R, Lima M do CA, Boscá L, Heras B de L, Abdalla DSP. Anti-inflammatory and antioxidant effects of a new arylidene-thiazolidinedione. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 19 res. FCF034.[citado 2024 out. 14 ]
Vancouver
Faine LA, Rudnicki M, César FA de, Galdino SL, Pitta I da R, Lima M do CA, Boscá L, Heras B de L, Abdalla DSP. Anti-inflammatory and antioxidant effects of a new arylidene-thiazolidinedione. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 19 res. FCF034.[citado 2024 out. 14 ]
Trabalho de evento-resumo periodico
Antiaterogenic and anti-inflamatory effects of new thiazolidine-2,4-diones (2010)
César, Fernanda Andrade de; Faine, Luciane Aparecida; Galdino, Suely Lins; Pitta, Ivan da Rocha; Lima, Maria do Carmo Alves; Abdalla, Dulcinéia Saes Parra
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidade: FCF
Assunto: ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÉSAR, Fernanda Andrade de et al. Antiaterogenic and anti-inflamatory effects of new thiazolidine-2,4-diones. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 out. 2024. , 2010
APA
César, F. A. de, Faine, L. A., Galdino, S. L., Pitta, I. da R., Lima, M. do C. A., & Abdalla, D. S. P. (2010). Antiaterogenic and anti-inflamatory effects of new thiazolidine-2,4-diones. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
César FA de, Faine LA, Galdino SL, Pitta I da R, Lima M do CA, Abdalla DSP. Antiaterogenic and anti-inflamatory effects of new thiazolidine-2,4-diones. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 25 res. FCF046.[citado 2024 out. 14 ]
Vancouver
César FA de, Faine LA, Galdino SL, Pitta I da R, Lima M do CA, Abdalla DSP. Antiaterogenic and anti-inflamatory effects of new thiazolidine-2,4-diones. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 25 res. FCF046.[citado 2024 out. 14 ]
Trabalho de evento-resumo periodico
New antidiabetic drugs of the thiazolidinediones class without inhibitory effects on alkaline phosphatase activity and matrix mineralization in mouse MC3T3-E1 osteoblasts (2010)
Saito, Cristiane Akemi Iamamoto; Rudnicki, Martina; César, Fernanda Andrade de; Faine, Luciane Aparecida; Galdino, Suely Lins; Pitta, Ivan da Rocha; Lima, Maria do Carmo Alves; Abdalla, Dulcinéia Saes Parra
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidade: FCF
Assunto: ANTIDIABÉTICOS (HIPOGLICEMIANTES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAITO, Cristiane Akemi Iamamoto et al. New antidiabetic drugs of the thiazolidinediones class without inhibitory effects on alkaline phosphatase activity and matrix mineralization in mouse MC3T3-E1 osteoblasts. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 out. 2024. , 2010
APA
Saito, C. A. I., Rudnicki, M., César, F. A. de, Faine, L. A., Galdino, S. L., Pitta, I. da R., et al. (2010). New antidiabetic drugs of the thiazolidinediones class without inhibitory effects on alkaline phosphatase activity and matrix mineralization in mouse MC3T3-E1 osteoblasts. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Saito CAI, Rudnicki M, César FA de, Faine LA, Galdino SL, Pitta I da R, Lima M do CA, Abdalla DSP. New antidiabetic drugs of the thiazolidinediones class without inhibitory effects on alkaline phosphatase activity and matrix mineralization in mouse MC3T3-E1 osteoblasts. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 51 res. FCF097.[citado 2024 out. 14 ]
Vancouver
Saito CAI, Rudnicki M, César FA de, Faine LA, Galdino SL, Pitta I da R, Lima M do CA, Abdalla DSP. New antidiabetic drugs of the thiazolidinediones class without inhibitory effects on alkaline phosphatase activity and matrix mineralization in mouse MC3T3-E1 osteoblasts. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 51 res. FCF097.[citado 2024 out. 14 ]

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Non normalized affiliation